Pivotal ECHO Study Provides Reassuring Evidence on HIV Risk and Contraceptives

Press Release: Pivotal ECHO Study Provides Reassuring Evidence on HIV Risk and Contraceptives Durban and New York – Results of a pivotal clinical trial among 7,829 women ages 16-35 in East and Southern Africa provide important evidence to help inform women’s choices...

‘Reassuring’ contraceptives and HIV trial also a wake-up call, experts say

‘Reassuring’ contraceptives and HIV trial also a wake-up call, experts say By Kelli RogersDevex There is no substantial difference in HIV risk among three highly effective methods of contraception, the results of a randomized clinical trial conducted in...

Depo-Provera, an Injectable Contraceptive, Does Not Raise H.I.V. Risk

Depo-Provera, an Injectable Contraceptive, Does Not Raise H.I.V. Risk By Donald G. McNeil Jr.The New York Times The hormone shot — popular among African women who must use birth control in secret — is as safe as other methods, scientists reported.      ...

Injectable Birth Control Increases HIV Risk by 40%

Injectable Birth Control Increases HIV Risk by 40% This article summarizes evidence from the Hapgood study concluding that women using the injectable progestin contraceptive depot medroxyprogesterone acetate, or DMPA, may face a substantially elevated risk for HIV...

Real Women Don’t Look Like Models

Real Women Don’t Look Like Models: What the latest paper on hormonal contraception and HIV risk leaves out By Emily Bass As the Echo trial continues its investigation on certain hormonal contraceptives and the possibility they increase the risk of acquiring HIV,...